Safety and Preliminary Efficacy of Early Tirofiban Treatment After Alteplase in Acute Ischemic Stroke Patients | Zendy

Wei Li | Zendy; Lin Lu | Zendy; Meng Zhang | Zendy; Ya Wu | Zendy; Chengchun Liu | Zendy; Xiaoshu Li | Zendy; Shuhan Huang | Zendy; ChunRong Liang | Zendy; YanJiang Wang | Zendy; Jinhua Chen | Zendy; Wuwei Feng | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Safety and Preliminary Efficacy of Early Tirofiban Treatment After Alteplase in Acute Ischemic Stroke Patients

Author(s) -

Wei Li,

Lin Lu,

Meng Zhang,

Ya Wu,

Chengchun Liu,

Xiaoshu Li,

Shuhan Huang,

ChunRong Liang,

YanJiang Wang,

Jinhua Chen,

Wuwei Feng

Publication year - 2016

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.116.014413

Subject(s) - medicine , tirofiban , modified rankin scale , stroke (engine) , incidence (geometry) , cohort , anesthesia , ischemic stroke , ischemia , myocardial infarction , mechanical engineering , physics , optics , percutaneous coronary intervention , engineering

We investigated whether early initiation of tirofiban, a glycoprotein IIb/IIIa antagonist, is safe, can reduce the risk of reocclusion, and improve outcomes in acute ischemic stroke patients after alteplase.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research